Abbate A, Trankle CR, Buckley LF, Lipinski MJ, Appleton D, Kadariya D, Canada JM, Carbone S, Roberts CS, Abouzaki N, Melchior R, Christopher S, Turlington J, Mueller G, Garnett J, Thomas C, Markley R, Wohlford GF, Puckett L, Van Tassell BW (2020) Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial infarction. J Am Heart Assoc 9(5):1–9. https://doi.org/10.1161/JAHA.119.014941
Allawadhi P, Khurana A, Sayed N, Kumari P, Godugu C (2018) Isoproterenol-induced cardiac ischemia and fibrosis: Plant-based approaches for intervention. Phytother Res 32(10):1908–1932. https://doi.org/10.1002/ptr.6152
Alyavi BA, Uzokov JK, Mukhitdinova O (2021) Antiplatelet therapy in coronary artery disease. Indian J Forensic Med Toxicol 15(3):2111–2115. https://doi.org/10.37506/ijfmt.v15i3.15628
Ambler J, Butler KD, Ku EC, Maguire ED, Smith JR, Wallis RB (1985) CGS 12970: a novel, long acting thromboxane synthetase inhibitor. Br J Pharmacol 86(2):497–504. https://doi.org/10.1111/j.1476-5381.1985.tb08920.x
Article CAS PubMed PubMed Central Google Scholar
Antoniak S, Rojas M, Spring D, Bullard TA, Verrier ED, Blaxall BC, Mackman N, Pawlinski R (2010) Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 30(11):2136–2142. https://doi.org/10.1161/ATVBAHA.110.213280
Article CAS PubMed PubMed Central Google Scholar
Badimon L, Vilahur G (2014) Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med 276(6):618–632. https://doi.org/10.1111/joim.12296
Article CAS PubMed Google Scholar
Badimon L, Padró T, Vilahur G (2012) Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Heart J Acute Cardiovasc Care 1(1):60–74. https://doi.org/10.1177/2048872612441582
Article PubMed PubMed Central Google Scholar
Bakogiannis C, Sachse M, Stamatelopoulos K, Stellos K (2019) Platelet-derived chemokines in inflammation and atherosclerosis. Cytokine 122:1–10. https://doi.org/10.1016/j.cyto.2017.09.013
Barbarawi M, Kheiri B, Zayed Y, Gakhal I, Al-Abdouh A, Barbarawi O, Rashdan L, Rizk F, Bachuwa G, Alkotob ML (2019) Aspirin efficacy in primary prevention: a meta-analysis of randomized controlled trials. High Blood Press Cardiovasc Prev 26(4):283–291. https://doi.org/10.1007/s40292-019-00325-5
Article CAS PubMed Google Scholar
Barisione G, Baroffio M, Crimi E, Brusasco V (2010) Beta-Adrenergic Agonists. Pharmaceuticals 3(4):1016–1044. https://doi.org/10.3390/ph3041016
Article CAS PubMed PubMed Central Google Scholar
Barrios V, Almendro-Delia M, Facila L, Garcia-Moll X, Mazon P, Camafort M, María Cepeda J, Mediavilla Garcia JD, Pose Reino A, Suarez Fernandez C (2018) Rivaroxaban: searching the integral vascular protection. Expert Rev Clin Pharmacol 11(7):719–728. https://doi.org/10.1080/17512433.2018.1495559
Article CAS PubMed Google Scholar
Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, De Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Muntner P (2018) Heart disease and stroke statistics - 2018 update: a report from the American Heart Association. Circulation 137(12):67–492. https://doi.org/10.1161/CIR.0000000000000558
Bentzon JF, Otsuka F, Virmani R, Falk E (2014) Mechanisms of plaque formation and rupture. Circ Res 114(12):1852–1866. https://doi.org/10.1161/CIRCRESAHA.114.302721
Article CAS PubMed Google Scholar
Bodor GS (2016) Biochemical markers of myocardial damage. J Int Fed Clin Chem Lab Med 27(2):95–111
Borissoff JI, Spronk HM, Heeneman S, Ten Cate H (2009) Is thrombin a key player in the “coagulation-atherogenesis” maze? Cardiovasc Res 82(3):392–403. https://doi.org/10.1093/cvr/cvp066
Article CAS PubMed Google Scholar
Borissoff JI, Heeneman S, Kilinç E, Kaššák P, Van Oerle R, Winckers K, Govers-Riemslag JW, Hamulyák K, Hackeng TM, Daemen MJ, Ten Cate H, Spronk HM (2010) Early atherosclerosis exhibits an enhanced procoagulant state. Circulation 122(8):821–830. https://doi.org/10.1161/CIRCULATIONAHA.109.907121
Article CAS PubMed Google Scholar
Busch G, Seitz I, Steppich B, Hess S, Eckl R, Schömig A, Ott I (2005) Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes implications in acute myocardial infarction. Atheroscler Thromb Vasc Biol 25(2):461–466. https://doi.org/10.1161/01.ATV.0000151279.35780.2d
Cammisotto V, Carnevale R, Nocella C, Stefanini L, Bartimoccia S, Coluccia A, Silvestri R, Pignatelli P, Pastori D, Violi F (2019) Nox2-mediated platelet activation by glycoprotein (GP) VI: effect of rivaroxaban alone and in combination with aspirin. Biochem Pharmacol 163:111–118. https://doi.org/10.1016/j.bcp.2019.02.016
Article CAS PubMed Google Scholar
Capodanno D, Mehran R, Valgimigli M, Baber U, Windecker S, Vranckx P, Dangas G, Rollini F, Kimura T, Collet JP, Gibson CM, Steg PG, Lopes RD, Gwon HC, Storey RF, Franchi F, Bhatt DL, Serruys PW, Angiolillo DJ (2018) Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention. Nat Rev Cardiol 15(8):480–496
Article CAS PubMed Google Scholar
Carretero A, Gomez-Cabrera MC, Rios-Navarro C, Salvador-Pascual A, Bodi V, Viña J (2020) Early reductive stress and late onset overexpression of antioxidant enzymes in experimental myocardial infarction. Free Radical Res 54(2–3):173–184. https://doi.org/10.1080/10715762.2020.1735632
Coppens M, Weitz JI, Eikelboom JW (2019) Synergy of dual pathway inhibition in chronic cardiovascular disease: lessons from the COMPASS trial. Circ Res 124(3):416–425. https://doi.org/10.1161/CIRCRESAHA.118.313141
Article CAS PubMed Google Scholar
Corbi G, Conti V, Russomanno G, Longobardi G, Furgi G, Filippelli A, Ferrara N (2013) Adrenergic signaling and oxidative stress: a role for sirtuins? Front Physiol 4:1–14. https://doi.org/10.3389/fphys.2013.00324
Daci A, Da Dalt L, Alaj R, Shurdhiqi S, Neziri B, Ferizi R, Norata GD, Krasniqi S (2020) Rivaroxaban improves vascular response in LPS-induced acute inflammation in experimental models. PLoS One 15(12):1–16. https://doi.org/10.1371/journal.pone.0240669
Dayana K, Manasa MR (2019) Evaluation of the effect of ceftriaxone on lipid peroxidation and antioxidant levels in mice. Biomed Pharmacol J 12(1):245–250. https://doi.org/10.13005/bpj/1634
De Candia E (2012) Mechanisms of platelet activation by thrombin: a short history. Thromb Res 129(3):250–256. https://doi.org/10.1016/j.thromres.2011.11.001
Article CAS PubMed Google Scholar
Dejana E, Callioni A, Quintana A (1979) Bleeding time in laboratory animals. II - a comparison of different assay conditions in rats. Thromb Res 15(1–2):191–197
Article CAS PubMed Google Scholar
Dhalla NS, Adameova A, Kaur M (2010) Role of catecholamine oxidation in sudden cardiac death. Fundam Clin Pharmacol 24(5):539–546. https://doi.org/10.1111/j.1472-8206.2010.00836.x
Article CAS PubMed Google Scholar
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Yusuf S (2017) Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 377(14):1319–1330. https://doi.org/10.1056/nejmoa1709118
Article CAS PubMed Google Scholar
Eller T, Busse J, Dittrich M, Flieder T, Alban S, Knabbe C, Birschmann I (2014) Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests. Clin Chem Lab Med 52(6):835–844. https://doi.org/10.1515/cclm-2013-0936
Article CAS PubMed Google Scholar
Forte E, Panahi M, Baxan N, Ng FS, Boyle JJ, Branca J, Bedard O, Muneer Hasham MG, Benson L, Harding SE, Rosenthal N, Sattler S (2021) Type 2 MI induced by a single high dose of isoproterenol in C57BL/6 J mice triggers a persistent adaptive immune response against the heart. J Cell Mol Med 25(1):229–243. https://doi.org/10.1111/jcmm.15937
Article CAS PubMed Google Scholar
Fuentes E, Moore-Carrasco R, de Andrade Paes AM, Trostchansky A (2019) Role of platelet activation and oxidative stress in the evolution of myocardial infarction. J Cardiovasc Pharmacol Ther 24(6):509–520. https://doi.org/10.1177/1074248419861437
Article CAS PubMed Google Scholar
Garlie JB, Hamid T, Gu Y, Ismahil MA, Chandrasekar B, Prabhu SD (2011) Tumor necrosis factor receptor 2 signaling limits β-adrenergic receptor-mediated cardiac hypertrophy in vivo. Basic Res Cardiol 106(6):1193–1205. https://doi.org/10.1007/s00395-011-0196-6
Article CAS PubMed Google Scholar
Gosselin R, Grant RP, Adcock DM (2016) Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays. Int J Lab Hematol 38(5):505–513. https://doi.org/10.1111/ijlh.12528
Article CAS PubMed Google Scholar
Graff J, Von Hentig N, Misselwitz F, Kubitza D, Becka M, Breddin HK, Harder S (2007) Effects of the oral, direct factor Xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity. J Clin Pharmacol 47(11):1398–1407. https://doi.org/10.1177/0091270007302952
Article CAS PubMed Google Scholar
Grant MK, Abdelgawad IY, Lewis CA, Seelig D, Zordoky BN (2020) Lack of sexual dimorphism in a mouse model of isoproterenol-induced cardiac dysfunction. PLoS One 15(7):1–19. https://doi.org/10.1371/journal.pone.0232507
留言 (0)